Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 84
Filter
1.
Viruses ; 15(12)2023 11 30.
Article in English | MEDLINE | ID: mdl-38140601

ABSTRACT

Molluscum contagiosum (MC) is characterized by skin lesions containing the highly contagious molluscum contagiosum poxvirus (MCV). MCV primarily infects children, with one US Food and Drug Administration (FDA)-approved drug-device treatment in use but no approved medications. Assessing antivirals is hindered by the inability of MCV to replicate in vitro. Here, we use vaccinia virus as a surrogate to provide evidence of the anti-poxvirus properties of berdazimer sodium, a new chemical entity, and the active substance in berdazimer gel, 10.3%, a nitric oxide-releasing topical in phase 3 development for the treatment of MC. We show that berdazimer sodium reduced poxvirus replication and, through a novel methodology, demonstrate that cells infected with drug-treated MCV virions have reduced early gene expression. Specifically, this is accomplished by studying the nuclear factor kappa-light-chain-enhancer of activated B cell (NF-kB)-blocking protein MC160 as an example of an early gene. The results provide a plausible unique antiviral mechanism of action supporting increased MCV resolution observed in patients treated with berdazimer gel, 10.3% and describe a novel methodology that overcomes limitations in investigating MCV response in vitro to a potential new MC topical medication.


Subject(s)
Molluscum Contagiosum , Molluscum contagiosum virus , United States , Child , Humans , Molluscum contagiosum virus/genetics , Molluscum Contagiosum/drug therapy , Siloxanes/metabolism , Antiviral Agents/pharmacology , Antiviral Agents/metabolism
2.
Exp Mol Pathol ; 134: 104876, 2023 12.
Article in English | MEDLINE | ID: mdl-37890651

ABSTRACT

Molluscum contagiosum virus (MCV) is a poxvirus that causes benign, persistent skin lesions. MCV encodes a variety of immune evasion molecules to dampen host immune responses. Two of these proteins are the MC159 and MC160 proteins. Both MC159 and MC160 contain two tandem death effector domains and share homology to the cellular FLIPs, FADD, and procaspase-8. MC159 and MC160 dampen several innate immune responses such as NF-κB activation and mitochondrial antiviral signaling (MAVS)-mediated induction of type 1 interferon (IFN). The type 1 IFN response is also activated by the cytosolic DNA sensors cyclic GMP-AMP synthase (cGAS) and stimulator of interferon genes (STING). Both cGAS and STING play a vital role in sensing a poxvirus infection. In this study, we demonstrate that there are nuanced differences between both MC160 and MC159 in terms of how the viral proteins modulate the cGAS/STING and MAVS pathways. Specifically, MC160 expression, but not MC159 expression, dampens cGAS/STING-mediated induction of IFN in HEK 293 T cells. Further, MC160 expression prevented the K63-ubiquitination of both STING and TBK1, a kinase downstream of cGAS/STING. Ectopic expression of the MC160 protein, but not the MC159 protein, resulted in a measurable decrease in the TBK1 protein levels as detected via immunoblotting. Finally, using a panel of MC160 truncation mutants, we report that the MC160 protein requires both DEDs to inhibit cGAS/STING-induced activation of IFN-ß. Our model indicates MC160 likely alters the TBK1 signaling complex to decrease IFN-ß activation at the molecular intersection of the cGAS/STING and MAVS signaling pathways.


Subject(s)
Molluscum contagiosum virus , Humans , Molluscum contagiosum virus/genetics , Molluscum contagiosum virus/metabolism , HEK293 Cells , Viral Proteins/genetics , Viral Proteins/metabolism , Nucleotidyltransferases/genetics , Nucleotidyltransferases/metabolism , Immunity, Innate , Interferon-beta/genetics , Interferon-beta/metabolism , Interferons/metabolism
3.
Antiviral Res ; 211: 105520, 2023 03.
Article in English | MEDLINE | ID: mdl-36603771

ABSTRACT

Molluscum contagiosum (MC) is an infectious disease that occurs only in humans with a tropism that is narrowly restricted to the outermost epidermal layer of the skin. Molluscum contagiosum virus (MCV) is the causative agent of MC which produces skin lesions that can persist for months to several years. MCV is efficiently transmitted by direct physical contact or by indirect contact with fomites. MC is most prevalent in children and immune compromised patients. The failure to develop a drug that targets MCV replication has been hampered for decades by the inability to propagate MCV in cell culture. To address this dilemma, we recently engineered a surrogate poxvirus expressing the MCV processivity factor (mD4) as the drug target. The mD4 protein is essential for viral replication by keeping the viral polymerase tethered to the DNA template. In this study we have designed and synthesized a lead compound (7269) that is able to prevent mD4 dependent processive DNA synthesis in vitro (IC50 = 6.8 µM) and effectively inhibit propagation of the mD4-VV surrogate virus in BSC-1 cells (EC50 = 13.2 µM) with negligible cytotoxicity. In human liver microsomes, 7269 was shown to be stable for almost 2 h. When tested for penetration into human cadaver skin in a formulated gel, the level of 7269 in the epidermal layer was nearly 100 times the concentration (EC50) needed to inhibit propagation of the mD4-VV surrogate virus in BSC-1 cells. The gel formulated 7269 was scored as a non-irritant on skin and shown to have a shelf-life that was completely stable after several months. In summary, 7269 is a potential Lead for becoming the first MCV anti-viral compound to treat MC and thereby, addresses this unmet medical need that has persisted for many decades.


Subject(s)
Molluscum Contagiosum , Molluscum contagiosum virus , Child , Humans , Molluscum contagiosum virus/genetics , Molluscum contagiosum virus/metabolism , Viral Proteins/genetics , DNA/metabolism
4.
Viruses ; 13(11)2021 10 20.
Article in English | MEDLINE | ID: mdl-34834914

ABSTRACT

Viral skin infections often affect the sports community. The aim of this study was to assess the rates, location sites, and seasons of appearance of common viral cutaneous diseases in beach volleyball athletes in Greece. Five hundred and forty-nine beach volleyball athletes participated in this study. The average age was 28.4 years. The viral infections were herpes simplex (type 1), molluscum contagiosum and warts. The measured parameters included: gender, age, the season when athletes may be more susceptible to infections and the location of infection in the body. Practicing information such as the number of training years, number of weekly trainings, and average hours of daily training was also recorded. Incidence rates correlated in relation to age: (a) warts (p < 0.001), molluscum contagiosum (p < 0.001), and herpes simplex (p = 0.001); (b) years of training: warts (p < 0.001), molluscum contagiosum (p < 0.001), and herpes simplex (p = 0.004); (c) average hours of daily training: molluscum contagiosum (p = 0.006) and herpes simplex (p < 0.010). The skin is the largest organ, and the risk of infection should not be underestimated. Prevention, early detection, recognition, and treatment are related to health and athletic performance, but also to the risk of transmission.


Subject(s)
Athletes/statistics & numerical data , Herpes Simplex/epidemiology , Molluscum Contagiosum/epidemiology , Molluscum contagiosum virus/isolation & purification , Skin Diseases/epidemiology , Warts/epidemiology , Adult , Female , Greece/epidemiology , Herpes Simplex/virology , Humans , Male , Molluscum Contagiosum/virology , Molluscum contagiosum virus/classification , Molluscum contagiosum virus/genetics , Molluscum contagiosum virus/physiology , Phylogeny , Simplexvirus/genetics , Simplexvirus/isolation & purification , Simplexvirus/physiology , Skin Diseases/virology , Volleyball , Warts/virology , Young Adult
5.
J Gen Virol ; 102(3)2021 03.
Article in English | MEDLINE | ID: mdl-31922947

ABSTRACT

Cases of pox-like lesions in horses and donkeys have been associated with poxviruses belonging to different genera of the family Poxviridae. These include the orthopoxviruses vaccinia virus (VACV), horsepoxvirus (HPXV) and cowpoxvirus (CPXV), as well as a potentially novel parapoxvirus and molluscum contagiosum virus (MOCV). However, with the exception of VACV, HPXV and CPXV, the genomic characterization of the causative agents remains largely elusive with only single short genome fragments available. Here we present the first full-length genome sequence of an equine molluscum contagiosum-like virus (EMCLV) directly determined from skin biopsies of a horse with generalized papular dermatitis. Histopathological analysis of the lesions revealed severe epidermal hyperplasia with numerous eosinophilic inclusion bodies within keratinocytes. Virions were detected in the lesions in embedded tissue by transmission electron microscopy. The genome sequence determined by next- and third-generation sequencing comprises 166 843 nt with inverted terminal repeats (ITRs) of 3473 nt. Overall, 20 of the predicted 159 ORFs have no equivalents in other poxviruses. Intriguingly, two of these ORFs were identified to encode homologues of mammalian proteins involved in immune signalling pathways, namely secreted and transmembrane protein 1 (SECTM1) and insulin growth factor-like family receptor 1 (IGFLR1), that were not described in any virus family so far. Phylogenetic analysis with all relevant representatives of the Poxviridae suggests that EMCLV should be nominated as a new species within the genus Molluscipoxvirus.


Subject(s)
Genome, Viral , Horse Diseases/virology , Molluscipoxvirus/genetics , Molluscipoxvirus/physiology , Poxviridae Infections/veterinary , Skin Diseases, Viral/veterinary , Viral Proteins/genetics , Animals , Female , High-Throughput Nucleotide Sequencing , Horses , Intercellular Signaling Peptides and Proteins/chemistry , Intercellular Signaling Peptides and Proteins/genetics , Intercellular Signaling Peptides and Proteins/metabolism , Membrane Proteins/chemistry , Membrane Proteins/genetics , Membrane Proteins/metabolism , Molluscipoxvirus/isolation & purification , Molluscum contagiosum virus/genetics , Open Reading Frames , Phylogeny , Poxviridae Infections/pathology , Poxviridae Infections/virology , Skin/pathology , Skin/virology , Skin Diseases, Viral/pathology , Skin Diseases, Viral/virology , Transcription, Genetic , Viral Proteins/chemistry , Viral Proteins/metabolism , Virus Replication/genetics , Whole Genome Sequencing
6.
J Virol ; 94(20)2020 09 29.
Article in English | MEDLINE | ID: mdl-32727873

ABSTRACT

Orthopoxviruses produce two antigenically distinct infectious enveloped virions termed intracellular mature virions and extracellular virions (EV). EV have an additional membrane compared to intracellular mature virions due to a wrapping process at the trans-Golgi network and are required for cell-to-cell spread and pathogenesis. Specific to the EV membrane are a number of proteins highly conserved among orthopoxviruses, including F13, which is required for the efficient wrapping of intracellular mature virions to produce EV and which plays a role in EV entry. The distantly related molluscipoxvirus, molluscum contagiosum virus, is predicted to encode several vaccinia virus homologs of EV-specific proteins, including the homolog of F13L, MC021L. To study the function of MC021, we replaced the F13L open reading frame in vaccinia virus with an epitope-tagged version of MC021L. The resulting virus (vMC021L-HA) had a small-plaque phenotype compared to vF13L-HA but larger than vΔF13L. The localization of MC021-HA was markedly different from that of F13-HA in infected cells, but MC021-HA was still incorporated in the EV membrane. Similar to F13-HA, MC021-HA was capable of interacting with both A33 and B5. Although MC021-HA expression did not fully restore plaque size, vMC021L-HA produced amounts of EV similar to those produced by vF13L-HA, suggesting that MC021 retained some of the functionality of F13. Further analysis revealed that EV produced from vMC021L-HA exhibit a marked reduction in target cell binding and an increase in dissolution, both of which correlated with a small-plaque phenotype.IMPORTANCE The vaccinia virus extracellular virion protein F13 is required for the production and release of infectious extracellular virus, which in turn is essential for the subsequent spread and pathogenesis of orthopoxviruses. Molluscum contagiosum virus infects millions of people worldwide each year, but it is unknown whether EV are produced during infection for spread. Molluscum contagiosum virus contains a homolog of F13L termed MC021L. To study the potential function of this homolog during infection, we utilized vaccinia virus as a surrogate and showed that a vaccinia virus expressing MC021L-HA in place of F13L-HA exhibits a small-plaque phenotype but produces similar levels of EV. These results suggest that MC021-HA can compensate for the loss of F13-HA by facilitating wrapping to produce EV and further delineates the dual role of F13 during infection.


Subject(s)
Cell Membrane , Membrane Proteins , Molluscum contagiosum virus , Vaccinia virus , Viral Envelope Proteins , Virion , Cell Membrane/genetics , Cell Membrane/metabolism , Cell Membrane/virology , Genetic Complementation Test , HeLa Cells , Humans , Membrane Proteins/genetics , Membrane Proteins/metabolism , Molluscum contagiosum virus/genetics , Molluscum contagiosum virus/metabolism , Vaccinia virus/genetics , Vaccinia virus/metabolism , Viral Envelope Proteins/genetics , Viral Envelope Proteins/metabolism , Virion/genetics , Virion/metabolism
7.
Acta Virol ; 63(3): 333-337, 2019.
Article in English | MEDLINE | ID: mdl-31507201

ABSTRACT

Molluscum contagiosum is a common, self-limiting infectious disease of the skin caused by molluscum contagiosum virus (MCV). The disease primarily affects children, sexually active adults, and immunocompromised individuals. Transmission of the virus occurs by direct skin contact. Therefore, the virus is usually detected in the skin and genitals of patients. However, the diagnosis of intracranial infection by the virus is difficult if the skin/mucosa lessons are atypical or absent, and the presence of the virus in the cerebrospinal fluid has not been reported. We report a very rare case of intracranial infection by molluscum contagiosum virus. A 25-year-old girl was admitted to our hospital due to severe headache but no fever or other symptoms. Upon examination, some small flesh-colored flattened papules on both arms were noticed. Blood tests showed slightly reduced levels of CD3 and CD4 T lymphocytes. Three-dimensional time-of-flight magnetic resonance angiography (3D-TOF-MRA) and head magnetic resonance (MR) were both normal. Lumbar puncture was performed, and metagenomic sequencing was applied to the spinal fluid. The unique sequences of the molluscum contagiosum virus were identified in the fluid. The patient was then diagnosed with intracranial molluscum contagiosum virus infection. No special treatment was given. The headache gradually disappeared, and the patient was discharged. During our quarterly follow-up, the girl appeared normal, and her skin lesions disappeared. However, her CD3 and CD4 T lymphocyte counts were still slightly lower than the normal level. Our case shows that the application of metagenomic sequencing to cerebrospinal fluid is a sensitive and powerful means to detect pathogens causing intracranial infection. Keywords: Molluscum contagiosum; intracranial infection; metagenomics sequencing.


Subject(s)
Metagenomics , Molluscum Contagiosum , Molluscum contagiosum virus , Adult , CD4-Positive T-Lymphocytes/cytology , Female , Humans , Lymphocyte Count , Molluscum Contagiosum/cerebrospinal fluid , Molluscum Contagiosum/diagnosis , Molluscum Contagiosum/immunology , Molluscum contagiosum virus/genetics , Skin/virology
8.
Viruses ; 10(11)2018 10 26.
Article in English | MEDLINE | ID: mdl-30373153

ABSTRACT

Molluscum contagiosum virus (MCV) is the sole member of the Molluscipoxvirus genus and the causative agent of molluscum contagiosum (MC), a common skin disease. Although it is an important and frequent human pathogen, its genetic landscape and evolutionary history remain largely unknown. In this study, ten novel complete MCV genome sequences of the two most common MCV genotypes were determined (five MCV1 and five MCV2 sequences) and analyzed together with all MCV complete genomes previously deposited in freely accessible sequence repositories (four MCV1 and a single MCV2). In comparison to MCV1, a higher degree of nucleotide sequence conservation was observed among MCV2 genomes. Large-scale recombination events were identified in two newly assembled MCV1 genomes and one MCV2 genome. One recombination event was located in a newly identified recombinant region of the viral genome, and all previously described recombinant regions were re-identified in at least one novel MCV genome. MCV genes comprising the identified recombinant segments have been previously associated with viral interference with host T-cell and NK-cell immune responses. In conclusion, the two most common MCV genotypes emerged along divergent evolutionary pathways from a common ancestor, and the differences in the heterogeneity of MCV1 and MCV2 populations may be attributed to the strictness of the constraints imposed by the host immune response.


Subject(s)
Genome, Viral , Genomics , Molluscum Contagiosum/virology , Molluscum contagiosum virus/genetics , Chemotaxis/immunology , Computational Biology/methods , Evolution, Molecular , Genetic Variation , Genomics/methods , Genotype , High-Throughput Nucleotide Sequencing , Humans , Immunity , Killer Cells, Natural/immunology , Killer Cells, Natural/metabolism , Molecular Sequence Annotation , Molluscum Contagiosum/immunology , Molluscum contagiosum virus/immunology , Mosaicism , Phylogeny , Recombination, Genetic , T-Lymphocytes/immunology , T-Lymphocytes/metabolism , Viral Load
9.
J Gen Virol ; 99(2): 246-252, 2018 02.
Article in English | MEDLINE | ID: mdl-29393023

ABSTRACT

Molluscum contagiosum virus (MCV) causes persistent, benign skin neoplasm in children and adults. MCV is refractive to growth in standard tissue culture and there is no relevant animal model of infection. Here we investigated whether another poxvirus (vaccinia virus; VACV) could be used to examine MCV immunoevasion protein properties in vivo. The MCV MC159L or MC160L genes, which encode NF-κB antagonists, were inserted into an attenuated VACV lacking an NF-κB antagonist (vΔA49), creating vMC159 and vMC160. vMC160 slightly increased vΔA49 virulence in the intranasal and intradermal routes of inoculation. vMC159 infection was less virulent than vΔA49 in both inoculation routes. vMC159-infected ear pinnae did not form lesions, but virus replication still occurred. Thus, the lack of lesions was not due to abortive virus replication. This system provides a new approach to examine MCV immunoevasion proteins within the context of a complete and complex immune system.


Subject(s)
Molluscum contagiosum virus/immunology , NF-kappa B/antagonists & inhibitors , Vaccinia virus/pathogenicity , Viral Proteins/administration & dosage , Administration, Intranasal , Animals , Child , Female , Humans , Injections, Intradermal , Mice, Inbred BALB C , Molluscum contagiosum virus/genetics , Viral Proteins/immunology , Virulence
10.
J Gen Virol ; 98(5): 1073-1079, 2017 May.
Article in English | MEDLINE | ID: mdl-28555548

ABSTRACT

Molluscum contagiosum virus (MCV) is the sole member of the Molluscipoxvirus genus and causes a highly prevalent human disease of the skin characterized by the formation of a variable number of lesions that can persist for prolonged periods of time. Two major genotypes, subtype 1 and subtype 2, are recognized, although currently only a single complete genomic sequence corresponding to MCV subtype 1 is available. Using next-generation sequencing techniques, we report the complete genomic sequence of four new MCV isolates, including the first one derived from a subtype 2. Comparisons suggest a relatively distant evolutionary split between both MCV subtypes. Further, our data illustrate concurrent circulation of distinct viruses within a population and reveal the existence of recombination events among them. These results help identify a set of MCV genes with potentially relevant roles in molluscum contagiosum epidemiology and pathogenesis.


Subject(s)
Genome, Viral , Molluscum contagiosum virus/classification , Molluscum contagiosum virus/genetics , Recombination, Genetic , Child , Cluster Analysis , Healthy Volunteers , High-Throughput Nucleotide Sequencing , Humans , Molluscum contagiosum virus/growth & development , Molluscum contagiosum virus/isolation & purification , Phylogeny , Sequence Analysis, DNA , Sequence Homology
11.
Virus Genes ; 53(4): 522-531, 2017 Aug.
Article in English | MEDLINE | ID: mdl-28425034

ABSTRACT

The molluscum contagiosum virus (MCV) uses a variety of immune evasion strategies to antagonize host immune responses. Two MCV proteins, MC159 and MC160, contain tandem death effector domains (DEDs). They are reported to inhibit innate immune signaling events such as NF-κB and IRF3 activation, and apoptosis. The RxDL motif of MC159 is required for inhibition of both apoptosis and NF-κB activation. However, the role of the conserved RxDL motif in the MC160 DEDs remained unknown. To answer this question, we performed alanine mutations to neutralize the arginine and aspartate residues present in the MC160 RxDL in both DED1 and DED2. These mutations were further modeled against the structure of the MC159 protein. Surprisingly, the RxDL motif was not required for MC160's ability to inhibit MAVS-induced IFNß activation. Further, unlike previous results with the MC159 protein, mutations within the RxDL motif of MC160 had no effect on the ability of MC160 to dampen TNF-α-induced NF-κB activation. Molecular modeling predictions revealed no overall changes to the structure in the MC160 protein when the amino acids of both RxDL motifs were mutated to alanine (DED1 = R67A D69A; DED2 = R160A D162A). Taken together, our results demonstrate that the RxDL motifs present in the MC160 DEDs are not required for known functions of the viral protein.


Subject(s)
Immune Evasion , Molluscum Contagiosum/virology , Molluscum contagiosum virus/immunology , Viral Proteins/chemistry , Viral Proteins/immunology , Amino Acid Motifs , Apoptosis , Humans , Interferon-beta/genetics , Interferon-beta/immunology , Molluscum Contagiosum/genetics , Molluscum Contagiosum/immunology , Molluscum Contagiosum/physiopathology , Molluscum contagiosum virus/chemistry , Molluscum contagiosum virus/genetics , Protein Domains , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/immunology , Viral Proteins/genetics
12.
Lakartidningen ; 1132016 11 28.
Article in Swedish | MEDLINE | ID: mdl-27898140

ABSTRACT

Molluscum contagiosum is a viral infection of the epidermis characterized by skin-colored papules or nodules frequently with a central depression. Atypical variants may occur, primarily in immunosuppressed individuals. We here report a case of ¼giant Molluscum contagiosum« in an immunocompetent child. The patient was presented with a fairly smooth nodule of 2 cm in diameter on the ring finger. Molluscipoxvirus-like virus particles were detected by electron microscopy from the nodule, but since the clinical picture was not compatible with MC, next generation sequencing was performed in order to verify the diagnosis.  Of the total number of obtained sequences, 25% belonged to molluscipoxvirus (MCV) and de novo assembly revealed three contigs corresponding to 95% of the MCV genome. The assembled genome was compared to previously published sequences of the ¼major envelope protein« used for genotyping of MCV genus. Several unique single nucleotide polymorphisms were identified, which led us to classify this virus as a new subtype of MCV.


Subject(s)
Molluscum Contagiosum/diagnosis , Molluscum contagiosum virus/isolation & purification , Child, Preschool , Female , Fingers/virology , High-Throughput Nucleotide Sequencing , Humans , Microscopy, Electron , Molluscum contagiosum virus/genetics , Sequence Analysis, DNA
13.
J Virol ; 90(9): 4469-4480, 2016 May.
Article in English | MEDLINE | ID: mdl-26889040

ABSTRACT

UNLABELLED: Molluscum contagiosum virus (MOCV), the only circulating human-specific poxvirus, has a worldwide distribution and causes benign skin lesions that may persist for months in young children and severe infections in immunosuppressed adults. Studies of MOCV are restricted by the lack of an efficient animal model or a cell culture replication system. We used next-generation sequencing to analyze and compare polyadenylated RNAs from abortive MOCV infections of several cell lines and a human skin lesion. Viral RNAs were detected for 14 days after MOCV infection of cultured cells; however, there was little change in the RNA species during this time and a similar pattern occurred in the presence of an inhibitor of protein synthesis, indicating a block preventing postreplicative gene expression. Moreover, a considerable number of MOCV RNAs mapped to homologs of orthopoxvirus early genes, but few did so to homologs of intermediate or late genes. The RNAs made during in vitro infections represent a subset of RNAs detected in human skin lesions which mapped to homologs of numerous postreplicative as well as early orthopoxvirus genes. Transfection experiments using fluorescent protein and luciferase reporters demonstrated that vaccinia virus recognized MOCV intermediate and late promoters, indicating similar gene regulation. The specific recognition of the intermediate promoter in MOCV-infected cells provided evidence for the synthesis of intermediate transcription factors, which are products of early genes, but not for late transcription factors. Transcriptome sequencing (RNA-seq) and reporter gene assays may be useful for testing engineered cell lines and conditions that ultimately could provide an in vitro replication system. IMPORTANCE: The inability to propagate molluscum contagiosum virus, which causes benign skin lesions in young children and more extensive infections in immunosuppressed adults, has constrained our understanding of the biology of this human-specific virus. In the present study, we characterized the RNAs synthesized in abortively infected cultured cells and a human skin lesion by next-generation sequencing. These studies provided an initial transcription map of the MOCV genome, suggested temporal regulation of gene expression, and indicated that the in vitro replication block occurs prior to intermediate and late gene expression. RNA-seq and reporter assays, as described here, may help to further evaluate MOCV gene expression and define conditions that could enable MOCV replication in vitro.


Subject(s)
Gene Expression Regulation, Viral , Molluscum Contagiosum/pathology , Molluscum Contagiosum/virology , Molluscum contagiosum virus/genetics , Transcriptome , Cell Line , Cells, Cultured , Computational Biology/methods , Consensus Sequence , Gene Expression Profiling , Gene Order , Genes, Viral , Genome, Viral , Humans , Molecular Sequence Annotation , Molluscum contagiosum virus/ultrastructure , Promoter Regions, Genetic , RNA, Viral , Sequence Analysis, DNA
14.
Adv Virus Res ; 92: 201-52, 2015.
Article in English | MEDLINE | ID: mdl-25701888

ABSTRACT

Molluscum contagiosum virus (MCV) is the causative agent of molluscum contagiosum (MC), the third most common viral skin infection in children, and one of the five most prevalent skin diseases worldwide. No FDA-approved treatments, vaccines, or commercially available rapid diagnostics for MCV are available. This review discusses several aspects of this medically important virus including: physical properties of MCV, MCV pathogenesis, MCV replication, and immune responses to MCV infection. Sequencing of the MCV genome revealed novel immune evasion molecules which are highlighted here. Special attention is given to the MCV MC159 and MC160 proteins. These proteins are FLIPs with homologs in gamma herpesviruses and in the cell. They are of great interest because each protein regulates apoptosis, NF-κB, and IRF3. However, the mechanism that each protein uses to impart its effects is different. It is important to elucidate how MCV inhibits immune responses; this knowledge contributes to our understanding of viral pathogenesis and also provides new insights into how the immune system neutralizes virus infections.


Subject(s)
Immune Evasion , Molluscum Contagiosum/immunology , Molluscum contagiosum virus/immunology , Animals , Host-Pathogen Interactions , Humans , Molluscum Contagiosum/virology , Molluscum contagiosum virus/genetics , Viral Proteins/genetics , Viral Proteins/immunology
15.
J Virol ; 90(6): 2895-905, 2015 Dec 30.
Article in English | MEDLINE | ID: mdl-26719271

ABSTRACT

UNLABELLED: Molluscum contagiosum virus (MCV) gene MC159 encodes a viral FLICE inhibitory protein (vFLIP) that inhibits caspase-8-mediated apoptosis. The MC159 protein was also reported to inhibit programmed necrosis (necroptosis) and modulate NF-κB activation by interacting with RIP1 and NEMO. The importance of MC159 during MCV infection has remained unknown, as there is no system for propagation and genetic manipulation of this virus. Here we investigated the functions of MC159 during viral infection using murine cytomegalovirus (MCMV) as a surrogate virus. MC159 was inserted into the MCMV genome, replacing M36 or M45, two MCMV genes with functions similar to those reported for MC159. M36 encodes a viral inhibitor of caspase-8-induced apoptosis (vICA) and M45 a viral inhibitor of RIP activation (vIRA), which inhibits RIP1/RIP3-mediated necroptosis. The M45 protein also blocks NF-κB activation by interacting with NEMO. When expressed by MCMV, MC159 blocked tumor necrosis factor alpha (TNF-α)-induced apoptosis of infected cells and partially restored MCMV replication in macrophages. However, MC159 did not fully replace M45, as it did not inhibit necroptosis in murine cells, but it reduced TNF-α-induced necroptosis in MCMV-infected human HT-29 cells. MC159 also differed from M45 in its effect on NF-κB. While MCMV-encoded M45 blocked NF-κB activation by TNF-α and interleukin-1ß (IL-1ß), MC159 inhibited TNF-α- but not IL-1ß-induced NF-κB activation in infected mouse fibroblasts. These results indicate that the spectrum of MC159's functions differs depending on cell type and expression system and that a cell culture system for the propagation of MCV is needed to determine the biological relevance of presumed viral gene functions. IMPORTANCE: MCV is a human-pathogenic poxvirus that cannot be propagated in cell culture or laboratory animals. Therefore, MCV gene products have been studied predominantly in cells expressing individual viral genes. In this study, we analyzed the function of the MCV gene MC159 by expressing it from a different virus and comparing its functions to those of two well-characterized MCMV genes. In this system, MC159 displayed some but not all of the previously described functions, suggesting that the functions of a viral gene depend on the conditions under which it is expressed. Until a cell culture system for the analysis of MCV becomes available, it might be necessary to analyze MCV genes in several different systems to extrapolate their biological importance.


Subject(s)
Apoptosis Regulatory Proteins/metabolism , Immunologic Factors/metabolism , Molluscum contagiosum virus/physiology , Muromegalovirus/physiology , Viral Proteins/metabolism , Animals , Cell Line , Cell Survival , Humans , Mice , Molluscum contagiosum virus/genetics , Molluscum contagiosum virus/immunology , Muromegalovirus/genetics , Muromegalovirus/immunology , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Viral Proteins/genetics
16.
Am J Dermatopathol ; 37(8): e93-5, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25140667

ABSTRACT

Langerhans cell histiocytosis (LCH) carries a prognosis, which ranges from benign to potentially fatal. There is currently little framework to decipher metrics, which predict the benign versus aggressive nature of LCH. We wanted to determine whether molluscum contagiosum virus (MCV) DNA could be isolated from a cutaneous lesion, demonstrating Langerhans cell hyperplasia resembling LCH in a patient with both. Polymerase chain reaction on biopsy-proven MCV and the hyperplastic lesion has been performed. Two specific regions within the MCV genome were detected from both biopsies. The authors report our findings and suggest that some MCV can produce histological lesions resembling LCH, similar to the literature on scabies mimicking LCH. Efforts to find a reactive "driver" in LCH may significantly inform the clinical scenario.


Subject(s)
DNA, Viral/analysis , Histiocytosis, Langerhans-Cell/pathology , Histiocytosis, Langerhans-Cell/virology , Langerhans Cells/pathology , Molluscum Contagiosum/complications , Adolescent , Antigens, CD1/analysis , Histiocytosis, Langerhans-Cell/metabolism , Humans , Hyperplasia/pathology , Hyperplasia/virology , Male , Molluscum contagiosum virus/genetics , S100 Proteins/analysis
17.
Antimicrob Agents Chemother ; 58(12): 7383-9, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25267668

ABSTRACT

The dermatological disease molluscum contagiosum (MC) presents as lesions restricted solely to the skin. The poxvirus molluscum contagiosum virus (MCV) is responsible for this skin disease that is easily transmitted through casual contact among all populations, with greater frequency in children and immunosuppressed individuals. In addition, sexual transmission of MCV in adolescents and adults is a health concern. Although the skin lesions ultimately resolve in immunocompetent individuals, they can persist for extended periods, be painful, and result in scarring. Treatment is problematic, and there is no drug that specifically targets MCV. The inability of MCV to propagate in cell culture has impeded drug development. To overcome these barriers, we integrated three new developments. First, we identified a new MCV drug target (mD4) that is essential for processive DNA synthesis in vitro. Second, we discovered a small chemical compound that binds to mD4 and prevents DNA synthesis in vitro. Third, and most significant, we engineered a hybrid vaccinia virus (mD4-VV) in which the natural vaccinia D4 (vD4) gene is replaced by the mD4 target gene. This hybrid virus is dependent on mD4 for viral growth in culture and is inhibited by the small compound. This target system provides, for the first time, a platform and approach for the discovery and evaluation of new therapeutics that can be used to treat MC.


Subject(s)
DNA, Viral , DNA-Directed DNA Polymerase/genetics , Molluscum contagiosum virus/genetics , Reassortant Viruses/genetics , Viral Proteins/genetics , Animals , Antiviral Agents/chemistry , Antiviral Agents/pharmacology , Biological Assay , Cell Line , Chlorocebus aethiops , Cloning, Molecular , DNA-Directed DNA Polymerase/metabolism , Drug Discovery , Epithelial Cells/drug effects , Epithelial Cells/pathology , Epithelial Cells/virology , Gene Expression , Humans , Kidney/drug effects , Kidney/pathology , Kidney/virology , Molecular Targeted Therapy , Molluscum contagiosum virus/drug effects , Molluscum contagiosum virus/metabolism , Plasmids/chemistry , Plasmids/metabolism , Rabbits , Reassortant Viruses/drug effects , Reassortant Viruses/metabolism , Recombinant Proteins , Small Molecule Libraries/chemistry , Small Molecule Libraries/pharmacology , Vaccinia virus/drug effects , Vaccinia virus/genetics , Vaccinia virus/metabolism , Viral Proteins/antagonists & inhibitors , Viral Proteins/metabolism
18.
Proc Natl Acad Sci U S A ; 111(2): E265-72, 2014 Jan 14.
Article in English | MEDLINE | ID: mdl-24379396

ABSTRACT

Apoptosis, NF-κB activation, and IRF3 activation are a triad of intrinsic immune responses that play crucial roles in the pathogenesis of infectious diseases, cancer, and autoimmunity. FLIPs are a family of viral and cellular proteins initially found to inhibit apoptosis and more recently to either up- or down-regulate NF-κB. As such, a broad role for FLIPs in disease regulation is postulated, but exactly how a FLIP performs such multifunctional roles remains to be established. Here we examine FLIPs (MC159 and MC160) encoded by the molluscum contagiosum virus, a dermatotropic poxvirus causing skin infections common in children and immunocompromised individuals, to better understand their roles in viral pathogenesis. While studying their molecular mechanisms responsible for NF-κB inhibition, we discovered that each protein inhibited IRF3-controlled luciferase activity, identifying a unique function for FLIPs. MC159 and MC160 each inhibited TBK1 phosphorylation, confirming this unique function. Surprisingly, MC159 coimmunoprecipitated with TBK1 and IKKε but MC160 did not, suggesting that these homologs use distinct molecular mechanisms to inhibit IRF3 activation. Equally surprising was the finding that the FLIP regions necessary for TBK1 inhibition were distinct from those MC159 or MC160 regions previously defined to inhibit NF-κB or apoptosis. These data reveal previously unappreciated complexities of FLIPs, and that subtle differences within the conserved regions of FLIPs possess distinct molecular and structural fingerprints that define crucial differences in biological activities. A future comparison of mechanistic differences between viral FLIP proteins can provide new means of precisely manipulating distinct aspects of intrinsic immune responses.


Subject(s)
Interferon-beta/antagonists & inhibitors , Molluscum Contagiosum/immunology , Molluscum contagiosum virus/genetics , Viral Proteins/metabolism , HEK293 Cells , Host-Pathogen Interactions , Humans , I-kappa B Kinase/metabolism , Immunoblotting , Immunoprecipitation , Luciferases/antagonists & inhibitors , Molluscum contagiosum virus/immunology , NF-kappa B/antagonists & inhibitors , Phosphorylation , Protein Serine-Threonine Kinases/metabolism , Viral Proteins/pharmacology
19.
J Virol Methods ; 187(2): 431-4, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23174165

ABSTRACT

A fluorescence resonance energy transfer (FRET)-based real-time PCR (RT-PCR) was developed for very sensitive and specific detection of Molluscum contagiosum virus (MCV), as well as reliable differentiation of the two MCV subtype genetic lineages, MCV1 and MCV2, in a single reaction. The assay employs modified primers specific for the viral MC021L gene and uses two novel FRET hybridization probes to detect polymorphisms specific for each of the two subtypes. The sensitivity of the assay at a 95% detection level for both MCV subtypes was 3.3 DNA copies/reaction and the dynamic range was nine orders of magnitude, discriminating 10-10(9) viral genome equivalents/reaction. Post-amplification probe-specific dissociation analysis differentiated the two viral subtypes reliably in all tested concentrations. Testing of 43 tissue specimens clinically diagnosed as MCV lesions showed complete agreement with the results obtained with previously described MCV specific MC080R Taqman RT-PCR and MC021L whole gene sequencing. The novel assay is simple, robust and easy to perform, and may be of great value for clinical and epidemiological studies of MCV infections and related conditions.


Subject(s)
Fluorescence Resonance Energy Transfer/methods , Molluscum contagiosum virus/classification , Molluscum contagiosum virus/isolation & purification , Real-Time Polymerase Chain Reaction/methods , Virology/methods , DNA Primers/genetics , Humans , Molluscum Contagiosum/virology , Molluscum contagiosum virus/genetics , Oligonucleotide Probes/genetics , Polymorphism, Genetic , Sensitivity and Specificity
20.
Methods Mol Biol ; 890: 135-46, 2012.
Article in English | MEDLINE | ID: mdl-22688765

ABSTRACT

Molluscum contagiosum virus (MCV), a poxvirus pathogenic for humans, replicates well in human skin in vivo, but not in vitro in standard monolayer cell cultures. In order to determine the nature of the replication deficiency in vitro, the MCV infection process in standard culture has to be studied step by step. The method described in this chapter uses luciferase and GFP reporter constructs to measure poxviral mRNA transcription activity in cells in standard culture infected with known quantities of MCV or vaccinia virus. Briefly, MCV isolated from human tissue specimen is quantitated by PCR and used to infect human HEK293 cells, selected for ease of transfection. The cells are subsequently transfected with a reporter plasmid encoding firefly luciferase gene under the control of a synthetic early/late poxviral promoter and a control plasmid encoding a renilla luciferase reporter under the control of a eukaryotic promoter. After 16 h, cells are harvested and tested for expression of luciferase. MCV genome units are quantitated by PCR targeting a genome area conserved between MCV and vaccinia virus. Using a GFP reporter plasmid, this method can be further used to infect a series of epithelial and fibroblast-type cell lines of human and animal origin to microscopically visualize MCV-infected cells, to assess late promoter activation, and, using these parameters, to optimize MCV infectivity and gene expression in more complex eukaryotic cell culture models.


Subject(s)
Molluscum contagiosum virus/pathogenicity , DNA, Viral/genetics , DNA, Viral/isolation & purification , Gene Expression , Gene Expression Regulation, Viral , Genes, Reporter , Genes, Viral , Green Fluorescent Proteins/biosynthesis , Green Fluorescent Proteins/genetics , HEK293 Cells , Humans , Luciferases, Firefly/biosynthesis , Luciferases, Firefly/genetics , Luciferases, Renilla/biosynthesis , Luciferases, Renilla/genetics , Molluscum contagiosum virus/genetics , Molluscum contagiosum virus/isolation & purification , Molluscum contagiosum virus/physiology , Plasmids/genetics , Promoter Regions, Genetic , Real-Time Polymerase Chain Reaction , Vaccinia virus/genetics , Vaccinia virus/growth & development , Vaccinia virus/pathogenicity , Virus Cultivation , Virus Replication
SELECTION OF CITATIONS
SEARCH DETAIL
...